A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis
- 30 September 1978
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 84 (4), 1112-1118
- https://doi.org/10.1016/0006-291x(78)91698-4
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Burimamide is a selective inhibitor of thromboxane-A biosynthesis in human platelet microsomesProstaglandins, 1978
- Inhibitors of thromboxane synthase in human plateletsFEBS Letters, 1977
- Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidneyNature, 1977
- Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane systhetaseBiochemical and Biophysical Research Communications, 1977
- Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosisProstaglandins, 1976
- Endogenous formation of the prostaglandin endoperoxine metabolite, thromboxane B2, by brain tissueBiochemical and Biophysical Research Communications, 1976
- Formation and Action of Prostaglandin Endoperoxides in the Isolated Human Umbilical ArteryActa Physiologica Scandinavica, 1976
- Prostaglandin Endoperoxides IX. Characterization of Rabbit Aorta Contracting Substance (RCS) from Guinea Pig Lung and Human PlateletsActa Physiologica Scandinavica, 1975
- The release of prostaglandins and rabbit aorta contracting substance (RCS) from rabbit spleen and its antagonism by anti‐inflammatory drugsBritish Journal of Pharmacology, 1972
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971